These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
486 related items for PubMed ID: 185039
1. [Familial hyperlipoproteinemia type III]. Patsch JR, Patsch W, Sailer S, Braunsteiner H. Dtsch Med Wochenschr; 1976 Oct 29; 101(44):1612-9. PubMed ID: 185039 [No Abstract] [Full Text] [Related]
2. A physician's guide to hyperlipidemia. Fredrickson DS. Mod Concepts Cardiovasc Dis; 1972 Jul 29; 41(7):31-6. PubMed ID: 4343098 [No Abstract] [Full Text] [Related]
4. Dietary and drug treatment of primary hyperlipoproteinemia. Ann Intern Med; 1972 Aug 29; 77(2):267-94. PubMed ID: 4345081 [No Abstract] [Full Text] [Related]
5. Treatment of hyperlipidemia. Levy RI, Morganroth J, Rifkind BM. N Engl J Med; 1974 Jun 06; 290(23):1295-301. PubMed ID: 4363888 [No Abstract] [Full Text] [Related]
6. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia. Patsch JR, Yeshurun D, Jackson RL, Gotto AM. Am J Med; 1977 Dec 06; 63(6):1001-9. PubMed ID: 204188 [No Abstract] [Full Text] [Related]
7. Hyperlipoproteinemia. Some basic concepts on diagnosis and management. Levy RI. JAMA; 1973 Nov 05; 226(6):648-9. PubMed ID: 4356846 [No Abstract] [Full Text] [Related]
8. Bile acid metabolism in hyperlipoproteinaemia. Hellström K, Einarsson K. Clin Gastroenterol; 1977 Jan 05; 6(1):103-28. PubMed ID: 196796 [No Abstract] [Full Text] [Related]
9. [Hyperlipoproteinemia]. Meinders AE. Ned Tijdschr Geneeskd; 1979 Mar 14; 123(15):617-28. PubMed ID: 219378 [No Abstract] [Full Text] [Related]
10. Clofibrate and related compounds in hyperlipoproteinaemia. A review. Gustafson A. Postgrad Med J; 1975 Mar 14; 51(8):suppl 66-71. PubMed ID: 215983 [No Abstract] [Full Text] [Related]
11. Familial hyperlipidemias. Diagnosis and treatment. Fleischmajer R, Dowlati Y, Reeves JR. Arch Dermatol; 1974 Jul 14; 110(1):43-50. PubMed ID: 4371196 [No Abstract] [Full Text] [Related]
12. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy. Falko JM, Witztum JL, Schonfeld G, Weidman SW, Kolar JB. Am J Med; 1979 Feb 14; 66(2):303-10. PubMed ID: 218451 [No Abstract] [Full Text] [Related]
13. [The problem of type changes in hyperlipoproteinemia (type IIb, IV, V) under clofibrate and m-inositol nicotinate therapy]. Schwartzkopff W, Zschiedrich M. Verh Dtsch Ges Inn Med; 1976 Feb 14; 82 Pt 1():825-9. PubMed ID: 196436 [No Abstract] [Full Text] [Related]
14. Antihyperlipidaemic agents. Witte EC. Prog Med Chem; 1975 Feb 14; 11():119-92. PubMed ID: 165566 [No Abstract] [Full Text] [Related]
15. The primary hyperlipoproteinemias. Bybee DE, Hamilton RD. J Ky Med Assoc; 1974 Dec 14; 72(12):658-62. PubMed ID: 4373515 [No Abstract] [Full Text] [Related]
16. Type IV hyperlipoproteinaemia. Kwiterovich PO, Margolis S. Clin Endocrinol Metab; 1973 Mar 14; 2(1):41-71. PubMed ID: 4359117 [No Abstract] [Full Text] [Related]
17. [The when and how of therapy for hyperlipoproteinemia]. Mordasini R. Schweiz Med Wochenschr; 1978 Jan 28; 108(4):113-9. PubMed ID: 203028 [Abstract] [Full Text] [Related]
18. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia]. Weisweiler P, Schwandt P. Verh Dtsch Ges Inn Med; 1978 Jan 28; 83():398-401. PubMed ID: 206058 [No Abstract] [Full Text] [Related]
19. Lipid lowering drugs and hyperlipidaemia. Levy RI, Rifking BM. Drugs; 1973 Jan 28; 6(1):12-45. PubMed ID: 4361281 [No Abstract] [Full Text] [Related]